Flagship Pioneering, LLC
SEC insider (Form 3/4/5 filer). CIK 0001400240. Director & 10% Owner at Foghorn Therapeutics Inc. (FHTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 13, 2026. Located in CAMBRIDGE, MA.
Companies Flagship Pioneering, LLC has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Director, 10% Owner
Flagship Pioneering, LLC
CIK: 0001400240
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Foghorn Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
AwardIndirectPre-Funded Warrants to purchase Common Stock
2.2M shares at avg. $6.71- - Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
AwardIndirectSeries 1 Warrants to purchase Common Stock
1.1M shares- - Jan 13, 2026FHTX
Foghorn Therapeutics Inc.
AwardIndirectSeries 2 Warrants to purchase Common Stock
1.1M shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award Pre-Funded Warrants to purchase Common Stock | 2,235,468 | $6.71 | - | Indirect |
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award Series 1 Warrants to purchase Common Stock | 1,117,734 | - | - | Indirect |
| Jan 13, 2026 | FHTX Foghorn Therapeutics Inc. | Award Series 2 Warrants to purchase Common Stock | 1,117,734 | - | - | Indirect |
1-3 of 3 transactions